Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学AML Menin Inhibitor Research

Ghayas Issa

MD

🏢MD Anderson Cancer Center🌐USA

Assistant Professor, Department of Leukemia

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Ghayas Issa is a leading clinical investigator in menin inhibitor therapy for acute myeloid leukemia. He has been instrumental in the clinical development of revumenib, demonstrating its efficacy in KMT2A-rearranged and NPM1-mutant AML. His work has helped establish menin inhibition as a viable therapeutic strategy for genetically defined AML subsets.

Share:

🧪Research Fields 研究领域

Revumenib
KMT2A-rearranged AML
Menin inhibitors
Acute leukemia
Targeted therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Ghayas Issa 的研究动态

Follow Ghayas Issa's research updates

留下邮箱,当我们发布与 Ghayas Issa(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment